Baylor, Collaborators Pinpoint Potential Prognostic snoRNA Biomarker for Colorectal Cancer | GenomeWeb

NEW YORK (GenomeWeb) — A team led by researchers from the Baylor University Medical Center has identified a small nucleolar RNAs that shows promise as a biomarker for recurrence and shorter survival in colorectal cancer patients.

After lung cancer, colorectal cancer is the most commonly diagnosed cancer in the world and the most common cause of cancer death in Europe and the US. But despite treatment advances, cancer often returns which is the primary cause of death.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.